Point72 Asset Management’s Altimmune ALT Stock Holding History

Point72 Asset Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.05M	Buy	+665,289	New	+$2.82M	﹤0.01%	2287
2025 Q4	–	Sell	-476,926	Closed	-$1.8M	–	3886
2025 Q3	$1.8M	Buy	+476,926	New	+$1.84M	﹤0.01%	1483
2024 Q2	–	Sell	-7,600	Closed	-$77.4K	–	1822
2024 Q1	$77.4K	Sell	7,600 -1,238,900	-99%	-$12.6M	﹤0.01%	2032
2023 Q4	$14M	Buy	+1,246,500	New	+$5.2M	0.03%	566
2023 Q2	–	Sell	-13,987	Closed	-$59K	–	2133
2023 Q1	$59K	Buy	+13,987	New	+$166K	﹤0.01%	1750
2022 Q3	–	Sell	-609,100	Closed	-$7.13M	–	1385
2022 Q2	$7.13M	Buy	+609,100	New	+$3.76M	0.03%	607
2021 Q3	–	Sell	-1,564,654	Closed	-$15.4M	–	1021
2021 Q2	$15.4M	Buy	+1,564,654	New	+$21.4M	0.07%	346

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Point72 Asset Management's ALT Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Altimmune (ALT) in Q1 2026: 665,289 shares worth $2.05M. The stake represents ﹤0.01% of the portfolio and ranks #2287 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in ALT as recently as Q3 2025.

Point72 Asset Management first reported a position in ALT in Q2 2021 and has held it in 7 quarters since. The position peaked at $15.4M in Q2 2021. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

Point72 Asset Management held 665,289 shares of Altimmune worth $2.05M as of Q1 2026.
Altimmune was a new Point72 Asset Management position in Q1 2026.
Altimmune made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2287 holding.
Point72 Asset Management first reported a position in Altimmune in Q2 2021 and has held it in 7 quarters since.
Point72 Asset Management's Altimmune position peaked at $15.4M in Q2 2021.
173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.